Brief: Neuroone Medical Technologies Corp - Announces Successful Robotic-Assisted Drug Delivery Using Stereoced Platform - SEC Filing
27/08/2026 14:29
BRIEF-Neuroone Medical Technologies Corp - Announces Successful Robotic-Assisted Drug Delivery Using Stereoced Platform - SEC Filing Aug 27 (Reuters) - Neuroone Medical Technologies Corp NMTC.O:
NEUROONE MEDICAL TECHNOLOGIES CORP - ANNOUNCES SUCCESSFUL ROBOTIC-ASSISTED DRUG DELIVERY USING STEREOCED PLATFORM - SEC FILING
NEUROONE MEDICAL TECHNOLOGIES CORP - PLANS LAUNCH OF STEREOCED PLATFORM FOR HUMAN INVESTIGATIONAL CLINICAL STUDIES LATER THIS QUARTER - SEC FILING
NEUROONE MEDICAL TECHNOLOGIES CORP - STEREOCED REVENUE EXPECTED TO BE RECOGNIZED IN CURRENT FISCAL QUARTER - SEC FILING
Source text: [ID:n0001213900-26-094174]
Further company coverage: NMTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuroone Medical Technologies
See all newsBrief: Neuroone Medical Technologies Corp - Announces Successful Robotic-Assisted Drug Delivery Using Stereoced Platform - SEC Filing
NeuroOne Medical Technologies Corp reports results for the quarter ended June 30 - Earnings Summary
NeuroOne Medical Technologies Corp expected to post a loss of 22 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Coca-Cola Co, Mondelez, Zeta Global Holdings
NASDAQ RESUMED AT 09:00 AM